US 8618095
2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
granted A61PA61P17/02A61P19/02
Quick answer
US patent 8618095 (2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P17/02, A61P19/02, A61P29/00, A61P37/00